NuCare Pharmaceuticals, Inc.
FDA inspection history across 2 sites, 2002 to 2020
- 1
- Form 483
- 1
- Close-out
- 1
- Warning letter
Every document, by year
- Form 483
- Close-out
- Warning letter
2002: one warning letter; 2019: one close-out letter; 2020: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2002One warning letter, at Orange, California.
- 2019–20One close-out letter and one Form 483, at Orange, California and ORANGE, California.
Cited most
Across all NuCare Pharmaceuticals observations on file
- 21 CFR 211.137(a)Expiration dating1
The complete NuCare Pharmaceuticals file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Orange, California
One close-out letter and one warning letter · 2002 to 2019
Latest: Close-out, Sep 26, 2019 →ORANGE, California
One Form 483 · 2020 · 1 observation
Latest: Form 483, Jan 10, 2020 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2020-01-10 | 483 Form 483 | ORANGE, California | 1 | $99 |
| 2019-09-26 | Close-out Close-out letter | Orange, California | — | $99 |
| 2002-10-11 | Warning letter Warning letter | Orange, California | — | $99 |
Investigators on these documents
FEI number 3003294404 · most recent document Jan 10, 2020
About NuCare Pharmaceuticals, Inc.
How many FDA Form 483s has NuCare Pharmaceuticals, Inc. received?
FDA Intel has 1 Form 483 on file for NuCare Pharmaceuticals, Inc.; the most recent is dated Jan 10, 2020.
When was NuCare Pharmaceuticals, Inc. last inspected by FDA?
The most recent FDA inspection document on file for NuCare Pharmaceuticals, Inc. is a Form 483 dated Jan 10, 2020, for the site in ORANGE, California.
What did FDA cite at NuCare Pharmaceuticals, Inc.?
The regulations cited most in the observations on file for NuCare Pharmaceuticals, Inc. are 21 CFR 211.137(a) (Expiration dating), 1 time.
Has NuCare Pharmaceuticals, Inc. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for NuCare Pharmaceuticals, Inc.; the most recent is dated Oct 11, 2002.